Clinical impact of amyloid PET using 18F-florbetapir in patients with cognitive impairment and suspected Alzheimer's disease: a multicenter study.
Matsuda H, Okita K, Motoi Y, Mizuno T, Ikeda M, Sanjo N, Murakami K, Kambe T, Takayama T, Yamada K, Suehiro T, Matsunaga K, Yokota T, Tateishi U, Shigemoto Y, Kimura Y, Chiba E, Kawashima T, Tomo Y, Tachimori H, Kimura Y, Sato N.
Matsuda H, et al. Among authors: takayama t.
Ann Nucl Med. 2022 Dec;36(12):1039-1049. doi: 10.1007/s12149-022-01792-y. Epub 2022 Oct 4.
Ann Nucl Med. 2022.
PMID: 36194355
Free PMC article.